Sorrento plans to request priority evaluation and accelerated review from regulators to determine the best pathway to make any potential treatment available as soon as possible. https://www.precisionvaccinations.com/sorrento-therapeutics-sti-1499-acts-protective-shield-against-sars-cov-2-coronavirus-infection